• Search
  • Login
  • Register
Menu
  • BJH
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical trials

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19

Clinical trials

Ivosidenib plus azacitidine for patients with IDH1-mutated acute myeloid leukaemia

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • Highlights in chronic lymphocytic leukaemia
  • Highlights in chronic myeloid leukaemia
  • Highlights in lymphoma
  • Long-term outcomes of isatuximab in high-risk multiple myeloma
  • Highlights in multiple myeloma
  • Navigating secondary acute myeloid leukaemia in 2023
  • Highlights in acute myeloid leukaemia and myelodysplastic syndromes
  • Highlights in acute lymphoblastic leukaemia
  • New haematology reimbursements in Belgium
Clinical trials

Encouraging results with loncastuximab tesirine plus rituximab for DLBCL patients

Read more
Clinical trials

Prolonged PFS with zanubrutinib in untreated CLL/SLL patients

Read more
Clinical trials

Triple combination of obinutuzumab, acalabrutinib and venetoclax not (yet) recommended in pati...

Read more
Clinical trials

Lenalidomide plus rituximab is an efficient chemo-free alternative for patients with advanced ...

Read more
Clinical trials

Sutimlimab reduces haemolysis, anaemia, and fatigue in patients with CAD without transfusion r...

Read more
Clinical trials

MRD status post-ASCT as a powerful predictor of PFS and OS in patients with multiple myeloma

Read more
Clinical trials

Novel CAR T-cell therapy GPRC5D shows promise in treatment of multiple myeloma

Read more
Clinical trials

Abnormal menstrual bleeding in women treated with anticoagulants for venous thromboembolism

Read more
Previous 1 2 3 4 5 6 7 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2023